Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Emergent BioSolutions Stock Fell Today

TheMotleyFool

0 0

Why Emergent BioSolutions Stock Fell TodayPhoto, wide shot, wide-angle lens, Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png

Shares of Emergent BioSolutions (NYSE: EBS) were trading 3.8% lower as of 3:01 p.m. EDT on Tuesday. The decline came after the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) called for a pause in the administration of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine.

Emergent BioSolutions contracted to manufacture J&J's COVID-19 vaccine. Therefore, any long-term issues with the vaccine could potentially hurt Emergent.

Image source: Getty Images.

Source Fool.com

Like: 0

EBS

Teilen